Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
All >

News > Northern Europe

Please find below news about Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as about organisations from these countries.

Total search results: 4822 | Ordered by Date (descending)
1 2 3 ... 47 48 49  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. 2019-04-23
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. 2019-04-17
PureTech Health plc. (4/17/19). "Press Release: PureTech Health Announces Collaboration with Boehringer Ingelheim to Advance Immuno-oncology Product Candidates Using Its Lymphatic Targeting Platform". Boston, MA. 2019-04-17
Inivata Ltd.. (4/16/19). "Press Release: Inivata, Thermo Fisher Scientific, and Genomics England Successfully Complete First Phase of Study Assessing Plasma Samples and Potential of Liquid Biopsy". 2019-04-16
Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd. 2019-04-12
BioStrata Ltd.. (4/11/19). "Press Release: BioStrata Launches Targeted News Distribution Service for Life Science and Healthcare Companies". Cambridge. 2019-04-11
Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). 2019-04-09
Kymab Ltd.. (4/8/19). "Press Release: Kymab Appoints Simon Sturge as Chief Executive Officer". Cambridge. 2019-04-08
Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge. 2019-04-08
Calliditas Therapeutics AB. (4/5/19). "Press Release: Elmar Schnee and Diane Parks Proposed as New Board Members of Calliditas Therapeutics". Stockholm. 2019-04-05
Crescendo Biologics Ltd.. (4/4/19). "Press Release: Theodora Harold to Be Appointed New CEO at Crescendo Biologics". Cambridge. 2019-04-04
Gesynta Pharma AB. (4/4/19). "Press Release: Gesynta Pharma Secures 6 MEUR for Development Programs in Financing Round Led by Industrifonden". Solna. 2019-04-04
Exscientia Ltd.. (4/3/19). "Press Release: Exscientia Achieves Molecule Discovery Milestone as Part of GSK Collaboration". Oxford. 2019-04-03
ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. 2019-04-03
Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel. 2019-04-02
Centogene AG. (4/2/19). "Press Release: Centogene Announces the Appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman". Rostock & Berlin. 2019-04-02
Metrion Biosciences Ltd.. (4/1/19). "Press Release: Metrion Biosciences Closes Funding Round. Includes investment from o2h Ventures Therapeutics Fund". Cambridge. 2019-04-01
Cambridge Innovation Capital plc. (4/1/19). "Press Release: Cambridge Innovation Capital Completes £150 Million New Capital Raise". 2019-04-01
Mologic Ltd.. (4/1/19). "Press Release: Mologic Expands US and UK Operations. Strengthens Team as Part of Continued International Expansion – Bolsters US Presence with the Opening of Subsidiary in Boston, MA". Bedfordshire. 2019-04-01
Surface Oncology Inc.. (4/1/19). "Press Release: Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer". Cambridge, MA. 2019-04-01
Cell Mogrify Ltd.. (4/1/19). "Press Release: Mogrify Subsidiary Chondrogenix Secures Funding from SBRI Healthcare to Advance Regenerative Cartilage Therapy to the Clinic". Cambridge. 2019-04-01
Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge. 2019-03-28
ArcherDX, Inc.. (3/28/19). "Press Release: ArcherDX Announces Collaboration with University College London to Investigate the Novel Use of Cell-Free Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients". Boulder, CO. 2019-03-28
Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris. 2019-03-28
Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. 2019-03-27
Evaluate Ltd.. (3/26/19). "Press Release: Evaluate Ltd. Appoints Deborah Kobewka as Chief Executive Officer". London, Boston, MA & Tokyo. 2019-03-26
MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY. 2019-03-26
Enamine Ltd.. (3/26/19). "Press Release: Enamine Extends Multi-year Drug Discovery Collaboration with Lundbeck". Kiev. 2019-03-26
Aimmune Therapeutics, Inc.. (3/25/19). "Press Release: European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint. Company Intends to Submit European MAA in Mid-2019". Brisbane, CA. 2019-03-25
Exscientia Ltd.. (3/21/19). "Press Release: Celgene and Exscientia Enter 3-year AI Drug Discovery Collaboration Focused on Accelerating Drug Discovery in Oncology and Autoimmunity". Oxford. 2019-03-21
Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London. 2019-03-21
Cambridge Cancer Genomics Ltd.. (3/21/19). "Press Release: Genomics England and Cambridge Cancer Genomics (CCG.ai) Announce Immunotherapy Partnership". Cambridge. 2019-03-21
Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London. 2019-03-21
NeoPhore Ltd.. (3/20/19). "Press Release: NeoPhore Appoints Dr John Haurum as Non-Executive Director. Former F-star CEO Joins the Board of Directors". 2019-03-20
Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. 2019-03-19
Cell Mogrify Ltd.. (3/18/19). "Press Release: Mogrify Awarded $555,000 USD (£420,000 GBP) Innovate UK Funding to Accelerate Regenerative Cell Therapies". Cambridge. 2019-03-18
Orchard Therapeutics Ltd.. (3/18/19). "Press Release: Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer". Boston, MA & London. 2019-03-18
Celyad S.A.. (3/18/19). "Press Release: Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates". Mont-Saint-Guibert. 2019-03-18
Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford. 2019-03-14
AstraZeneca plc. (3/14/19). "Press Release: AstraZeneca Showcases Next-generation Oncology Pipeline Addressing Unmet Patient Needs at AACR Annual Meeting". 2019-03-14
MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan. 2019-03-13
Olink Proteomics. (3/12/19). "Press Release: Summa Equity Acquires Olink Proteomics". 2019-03-12
Oxford BioMedica plc. (3/12/19). "Press Release: Oxford Biomedica Announces R&D Collaboration with Microsoft to Improve Gene and Cell Therapy Manufacturing Using the Intelligent Cloud and Machine Learning". Oxford. 2019-03-12
Biogen Inc.. (3/12/19). "Press Release: Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm". Cambridge. 2019-03-12
ERS Genomics Ltd.. (3/12/19). "Press Release: ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent including Uses of CRISPR »in a Cell«". Dublin. 2019-03-12
Snipr Biome ApS. (3/11/19). "Press Release: Snipr Biome Raises $50 Million Series A Financing to Advance CRISPR-based Microbiome Drugs to Human Clinical Trials". Copenhagen. 2019-03-11
Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. 2019-03-11
Seres Therapeutics, Inc.. (3/11/19). "Press Release: Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca". Cambridge, MA. 2019-03-11
H. Lundbeck A/S. (3/8/19). "Press Release: Lundbeck Appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer". Valby. 2019-03-08
MorphoSys AG. (3/7/19). "Press Release: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL". Planegg. 2019-03-07
Agilent Technologies Inc.. (3/6/19). "Press Release: Agilent and Imperial College London Strengthen Partnership". Santa Clara, CA. 2019-03-06
Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma Announces Once-weekly TransCon Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency". 2019-03-04
Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma A/S Announces Proposed Public Offering of ADSs". Copenhagen. 2019-03-04
Nightstar Therapeutics plc. (3/4/19). "Press Release: Nightstar Therapeutics plc Reaches Agreement to Be Acquired by Biogen". 2019-03-04
AdoRx Therapeutics Ltd.. (2/28/19). "Press Release: AdoRx Therapeutics Announces Collaboration With Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics". Edinburgh. 2019-02-28
MeiraGTx Holdings plc. (2/27/19). "Press Release: MeiraGTx Announces $80 Million Private Placement of Ordinary Shares". London & New York, NY. 2019-02-27
CN Bio Innovations Ltd.. (2/27/19). "Press Release: CN Bio to Put Ten Organs on “Body-on-a-Chip”". London. 2019-02-27
Syncona Ltd.. (2/26/19). "Press Release: Syncona Leads CHF 35 Million Series A Financing in Anaveon, a New Immuno-oncology Company". 2019-02-26
Boehringer Ingelheim. (2/25/19). "Press Release: New Chief Medical Officer Appointed". Ingelheim. 2019-02-25
Orchard Therapeutics Ltd.. (2/25/19). "Press Release: Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD". Boston, MA & London. 2019-02-25
Orchard Therapeutics Ltd.. (2/22/19). "Press Release: Orchard Therapeutics Presents Two-year Follow-up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID". Boston, MA & London. 2019-02-22
Seventure Partners. (2/20/19). "Press Release: Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C". Paris. 2019-02-20
Cell Mogrify Ltd.. (2/20/19). "Press Release: Mogrify Raises $3.7 Million USD Seed Funding to Accelerate its Mission to Transform Cell Therapy via Direct Cellular Conversion". Cambridge. 2019-02-20
MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. 2019-02-19
Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2019-02-19
UCB S.A.. (2/15/19). "Press Release: UCB Builds on Its R&D Footprint to Form a Research Satellite Facility within King’s College London". Brussels & Slough. 2019-02-15
Sygnature Discovery Ltd.. (2/15/19). "Press Release: Sygnature Discovery Starts 2019 with Two Senior Appointments – Dr Allan Jordan and Ms Louisa Jordison". Nottingham. 2019-02-15
Follicum AB. (2/11/19). "Press Release: Follicum Selects Novel Peptide Drug Candidate for the Treatment of Diabetes and Protection of Beta Cells". 2019-02-11
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
UCB S.A.. (2/11/19). "Press Release: UCB and Epilepsy Society Announce Pioneering UK Genomics R&D collaboration". Slough & Brussels. 2019-02-11
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
Oxford BioMedica plc. (2/7/19). "Press Release: Oxford Biomedica Provides Update on Programmes Outlicensed to Sanofi". Oxford. 2019-02-07
Sygnature Discovery Ltd.. (2/7/19). "Press Release: Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership to Develop First in Class Therapies in Autoimmune Disease and Immuno-oncology". Oxford & Nottingham. 2019-02-07
GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. 2019-02-06
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven. 2019-02-06
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London. 2019-02-04
Avacta Group plc. (2/4/19). "Press Release: Moderna Exercises Option for an Exclusive Product License". 2019-02-04
Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London. 2019-02-04
Follicum AB. (2/4/19). "Press Release: Follicum’s New Topical Formulation of FOL-005 Results in Increased Hair Growth on a Par with Leading Commercial Product". 2019-02-04
MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. 2019-01-31
MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. 2019-01-31
Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. 2019-01-31
Orphazyme A/S. (1/30/19). "Press Release: Orphazyme Reports Positive Results from Full Data Set of Phase II/III Arimoclomol Tria in Niemann-Pick Disease Type C (NPC)". Copenhagen. 2019-01-30
BioStrata Ltd.. (1/29/19). "Press Release: BioStrata Announces New Hires to Drive Continued Growth across Its Specialist Marketing Communications Offering". Cambridge. 2019-01-29
Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge. 2019-01-28
Horizon Discovery Group plc. (1/28/19). "Press Release: Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology". Cambridge. 2019-01-28
Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. 2019-01-26
MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. 2019-01-26
Genomics England Ltd.. (1/25/19). "Press Release: Jonathan Symonds Appointed New Chair of Genomics England". 2019-01-25
Sartorius AG. (1/23/19). "Press Release: Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)". Göttingen & Glasgow. 2019-01-23
Genmab A/S. (1/22/19). "Press Release: Genmab Announces 2018 Net Sales Figures for Darzalex (Daratumumab)". Copenhagen. 2019-01-22
GlaxoSmithKline plc. (1/22/19). "Press Release: GSK Completes Acquisition of Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2019-01-22
Wren Therapeutics Ltd.. (1/22/19). "Press Release: Wren Therapeutics Completes £18 Million Series A Financing". Cambridge. 2019-01-22
Genmab A/S. (1/22/19). "Press Release: Genmab Announces Initiation of U.S. FDA Regulatory Submission for Label Expansion of Daratumumab in Combination with Lenalidomide and Dexamethasone in Front Line Multiple Myeloma". Copenhagen. 2019-01-22
Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. 2019-01-21
GlaxoSmithKline plc. (1/21/19). "Press Release: GSK Announces Succession Plan to Appoint New Chairman". 2019-01-21
Bavarian Nordic A/S. (1/18/19). "Press Release: Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN Smallpox Vaccine". Copenhagen. 2019-01-18
Autifony Therapeutics Ltd.. (1/18/19). "Press Release: Autifony Therapeutics Achieves First Milestone in Agreement with Boehringer Ingelheim for a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage. 2019-01-18
Immunocore Ltd.. (1/15/19). "Press Release: Immunocore Names David Berman as Head of R&D". Oxford & Conshohocken, PA. 2019-01-15
1 2 3 ... 47 48 49  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top